until now, the drug Gardasil was only approved for teenagers and
young adults. However, the FDA recently changed that with its
approval of Gardasil 9, a supplemental application that allows
individuals – men and women between 27 and 45 years of age – to
get the drug.
Peter Marks, FDA’s Center for Biologics Evaluation and Research
director, said the approval is an acknowledgment to help prevent
cancers and other HPV-related diseases in older adults.
to the CDC, HPV vaccination can help prevent over 90 percent of the
cancers associated with the STD. This translates to 31,200 cases each
year from being developed. The CDC estimates that 14 million
Americans are infected with HPV annually. 12,000 women with HPV
develop cervical cancer, with about 4,000 of those women dying from
men and women can develop various types of cancer because of HPV.
FDA first approved Gardasil in 2009 to stop certain HPV-cancers and disease, but is no longer being used in the U.S. The agency approved
the use of Gardasil 9 in 2014, covering nine kinds of HPV and was
initially approved for person nine to 26-years-old.
studying a group of 3,200 women between 27 and 45 years of age, the
agency noted Gardasil 9 was 88 percent effective in stopping the
development of genital warts, vaginal precancerous lesions, cervical
cancer, etc. The FDA said its approval of the drug for this age group
is based on the study conducted.
The most common side effect of the Gardasil 9 drug is swelling and redness at the shot site and headaches.